Sugar vs Tobacco: Should You Buy Associated British Foods plc, Tate & Lyle PLC or British American Tobacco plc?

Can Associated British Foods plc (LON:ABF) and Tate & Lyle PLC (LON:TATE) manage to tempt investors away from British American Tobacco plc (LON:BATS)?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

SugarIf I asked you to name a sin stock, you’d probably suggest British American Tobacco (LSE: BATS)).

You probably wouldn’t mention the UK’s sugar giants, Associated British Foods (LSE: ABF) (NASDAQOTH: ASBFY.US) and sweetener manufacturer Tate & Lyle (LSE: TATE).

Despite this, recent press coverage has suggested that both sugar and sweeteners could be linked to the west’s obesity and diabetes epidemic. This view isn’t yet universally accepted, but the evidence is mounting, and I believe investors need to consider the potential implications.

Tobacco 2, Sugar 0

Although sugar producers are never likely to face the kind of regulatory pressure under which tobacco firms trade, they do have a number of disadvantages, in my view:

Tobacco firms

Sugar producers

Consumers are intensely loyal to global brands, which drive premium pricing power and high profit margins.

Sugar and sweeteners are essentially commodities, the price of which can be driven down by excess supply.

Regulatory restrictions are well understood and managed by the industry. Scientific evidence against tobacco is mature and no longer controversial.

Potential for future regulation or dietary changes by consumers is completely unknown. Scientific evidence still mounting against sugar.

Having reluctantly accepted that tobacco is harmful, the growth of unregulated e-cigarettes is an example of how the tobacco industry is seeking to adapt to declining levels of smoking in Western countries.

BAT has recently gone a step further, backing a small British start-up firm that’s launching a medically approved nicotine inhaler, targeting “mature smokers” in western markets!

What about the financials?

Leaving the arguments aside, how do the numbers look? Are any of these firms a compelling buy in today’s market?

 

Associated British Foods

Tate & Lyle

British American Tobacco

2014 forecast P/E

25.7

14.8

16.9

2014 prospective yield

1.3%

3.9%

4.1%

Operating margin

8.0%

10.3%

38%

BAT’s incredible profit margins mean that it can afford to service a substantial debt pile and pay generous dividends to shareholders. With a P/E of nearly 17, BAT’s shares are fully valued, but this reflects the demand for income in today’s market.

In contrast, ABF looks plain expensive, with an uncomfortable forecast P/E of 25.7%, the lower profit margins of the three, and an unappealing 1.3% prospective yield.

Tate & Lyle is the cheapest of these three firms and offers a decent yield. However, weaker demand and pricing pressure on its key Sucralose product has triggered two profit warnings so far this year, and despite management’s reassurances, I’m not completely confident a third disappointment won’t be on the cards.

Today’s best buy?

In my view, ABF is simply too expensive, given its low yield and weak growth prospects.

Tate & Lyle looks a reasonable buy despite the risk of further profit weakness this year, but the strongest contender for income has to be British American Tobacco.

BAT’s high profit margins and low capital expenditure mean that it generates a lot of free cash flow, virtually all of which is returned to investors each year. I can’t see this changing in the near future.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head has no position in any shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Illustration of flames over a black background
Investing Articles

2 red-hot UK growth stocks to consider buying in April

These two growth stocks are performing well, but can they continue to deliver for investors through 2024 and beyond?

Read more »

Charticle

Is JD Sports Fashion one of the FTSE 100’s best value stocks? Here’s what the charts say!

The JD Sports Fashion share price remains a wild ride during the first quarter. Could it be one of the…

Read more »

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »